{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:40:38Z","timestamp":1782891638996,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH","doi-asserted-by":"publisher","award":["UH2\/UH3 DA041115"],"award-info":[{"award-number":["UH2\/UH3 DA041115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH","doi-asserted-by":"publisher","award":["R01 DA035552"],"award-info":[{"award-number":["R01 DA035552"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH","doi-asserted-by":"publisher","award":["R01 DA032910"],"award-info":[{"award-number":["R01 DA032910"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH","doi-asserted-by":"publisher","award":["R01 DA013930"],"award-info":[{"award-number":["R01 DA013930"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH","doi-asserted-by":"publisher","award":["R01 DA025100)"],"award-info":[{"award-number":["R01 DA025100)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation (NSF","doi-asserted-by":"publisher","award":["CHE-1111761"],"award-info":[{"award-number":["CHE-1111761"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cbi.2019.04.012","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T11:10:09Z","timestamp":1555067409000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Development of a long-acting Fc-fused cocaine hydrolase with improved yield of protein expression"],"prefix":"10.1016","volume":"306","author":[{"given":"Xiabin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xirong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.04.012_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2019.04.012_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cbi.2005.10.052","article-title":"(07) in vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia\u2122) as a potential nerve agent bioscavenger","volume":"157","author":"Cerasoli","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.04.012_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2006.11.066","article-title":"Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review","volume":"233","author":"Lenz","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2019.04.012_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-2952(91)90008-S","article-title":"Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice","volume":"41","author":"Ashani","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.012_bib5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0091-3057(93)90218-I","article-title":"Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats","volume":"46","author":"Brandeis","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.cbi.2019.04.012_bib6","first-page":"121","article-title":"Prophylaxis against soman inhalation toxicity in Guinea pigs by pretreatment alone with human serum butyrylcholinesterase","volume":"43","author":"Allon","year":"1998","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2019.04.012_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.62.2.220","article-title":"Re-engineering butyrylcholinesterase as a cocaine hydrolase","volume":"62","author":"Sun","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.012_bib8","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/sj.npp.1301666","article-title":"A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats","volume":"33","author":"Brimijoin","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cbi.2019.04.012_bib9","doi-asserted-by":"crossref","first-page":"12148","DOI":"10.1021\/ja803646t","article-title":"Most efficient cocaine hydrolase designed by virtual screening of transition states","volume":"130","author":"Zheng","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2019.04.012_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/mol.110.068494","article-title":"Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine","volume":"79","author":"Xue","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.012_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1039\/C3MB70313D","article-title":"A model of glycosylated human butyrylcholinesterase","volume":"10","author":"Fang","year":"2014","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.cbi.2019.04.012_bib12","doi-asserted-by":"crossref","first-page":"16656","DOI":"10.1073\/pnas.0507332102","article-title":"Computational redesign of human butyrylcholinesterase for anticocaine medication","volume":"102","author":"Pan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2019.04.012_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jcph.450","article-title":"Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects","volume":"55","author":"Cohen-Barak","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.012_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/JCP.0000000000000347","article-title":"Assessment of pharmacokinetic and pharmacodynamic interactions between albumin-fused mutated butyrylcholinesterase and intravenously administered cocaine in recreational cocaine users","volume":"35","author":"Shram","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cbi.2019.04.012_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4155\/fmc.11.171","article-title":"Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose?","volume":"4","author":"Zheng","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.cbi.2019.04.012_bib16","series-title":"Expression and Refoldin of Functional Human Butyrylcholinesterase From E. Coli. in Multidisciplinary Approaches to Cholinesterase Functions","first-page":"49","author":"Masson","year":"1992"},{"key":"10.1016\/j.cbi.2019.04.012_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-2952(00)00238-0","article-title":"High-level expression of human butyrylcholinesterase gene in Bombyx mori and biochemical-pharmacological characteristic study of its product","volume":"60","author":"Wei","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.012_bib18","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/j.1742-4658.2012.08672.x","article-title":"Human butyrylcholinesterase produced in insect cells: huprine\u2010based affinity purification and crystal structure","volume":"279","author":"Brazzolotto","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2019.04.012_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12896-016-0302-9","article-title":"Plant expression of cocaine hydrolase-Fc fusion protein for treatment of cocaine abuse","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.cbi.2019.04.012_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1467-7652.2010.00515.x","article-title":"Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase","volume":"8","author":"Geyer","year":"2010","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.cbi.2019.04.012_bib21","doi-asserted-by":"crossref","first-page":"13603","DOI":"10.1073\/pnas.0702756104","article-title":"Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning","volume":"104","author":"Huang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2019.04.012_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1472-6750-8-50","article-title":"Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin","volume":"8","author":"Huang","year":"2008","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.cbi.2019.04.012_bib23","series-title":"Cell Culture Processes for Monoclonal Antibody Production, MAbs","first-page":"466","author":"Li","year":"2010"},{"key":"10.1016\/j.cbi.2019.04.012_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/BJ20130549","article-title":"Preparation and in vivo characterization of a cocaine hydrolase engineered from human butyrylcholinesterase for metabolizing cocaine","volume":"453","author":"Xue","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2019.04.012_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/jpet.102.033746","article-title":"Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity","volume":"302","author":"Duysen","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.04.012_bib26","article-title":"Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys; a potential new therapeutic for protection against cocaine and nerve agent toxicity","volume":"3","author":"Lockridge","year":"2005","journal-title":"J. Med. Chem. Biol. Radiol. Def."},{"key":"10.1016\/j.cbi.2019.04.012_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt0293-187","article-title":"A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm","volume":"11","author":"Lavallie","year":"1993","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cbi.2019.04.012_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/protein\/11.6.495","article-title":"High level expression and secretion of Fc-X fusion proteins in mammalian cells","volume":"11","author":"Lo","year":"1998","journal-title":"Protein Eng."},{"key":"10.1016\/j.cbi.2019.04.012_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cbi.2019.04.012_bib30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/1087057114563494","article-title":"Gram scale Antibody production using CHO cell transient gene expression (TGE) via Flow electroporation","volume":"20","author":"Wang","year":"2015","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.cbi.2019.04.012_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1073\/pnas.1517713113","article-title":"Long-acting cocaine hydrolase for addiction therapy","volume":"113","author":"Chen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2019.04.012_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1208\/s12248-018-0214-9","article-title":"Development of Fc-fused cocaine hydrolase for cocaine addiction: catalytic and pharmacokinetic properties","volume":"20","author":"Chen","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.cbi.2019.04.012_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/BJ20141266","article-title":"Kinetic characterization of a cocaine hydrolase engineered from mouse butyrylcholinesterase","volume":"466","author":"Chen","year":"2015","journal-title":"Biochem. J."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719303552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719303552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:53:53Z","timestamp":1757858033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719303552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":33,"alternative-id":["S0009279719303552"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.04.012","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a long-acting Fc-fused cocaine hydrolase with improved yield of protein expression","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}